{"id":440634,"date":"2020-08-11T08:47:43","date_gmt":"2020-08-11T12:47:43","guid":{"rendered":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/greenbrook-tms-reports-second-quarter-financial-results-with-resilient-performance-through-the-covid-19-pandemic-business-wire-8.php"},"modified":"2020-08-11T08:47:43","modified_gmt":"2020-08-11T12:47:43","slug":"greenbrook-tms-reports-second-quarter-financial-results-with-resilient-performance-through-the-covid-19-pandemic-business-wire-8","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/tms\/greenbrook-tms-reports-second-quarter-financial-results-with-resilient-performance-through-the-covid-19-pandemic-business-wire-8.php","title":{"rendered":"Greenbrook TMS Reports Second Quarter Financial Results With Resilient Performance Through the COVID-19 Pandemic &#8211; Business Wire"},"content":{"rendered":"<p><p>TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (Greenbrook or the Company), today announced its second quarter 2020 (Q2 2020) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.<\/p>\n<p>SECOND QUARTER 2020 FINANCIAL AND OPERATIONAL HIGHLIGHTS<\/p>\n<p>Bill Leonard, President and Chief Executive Officer of Greenbrook commented:<\/p>\n<p>We are very pleased with our Q2 2020 results, which demonstrate our ability to navigate the challenging operating environment imposed by the COVID-19 pandemic. Overall, we were able to exceed previously disclosed revenue guidance while continuing to provide the highest quality of services and protecting our patients, employees, and physician partners. With access to TMS therapy now more essential than ever, we have increased efforts to expand patient interactions virtually and the corresponding increased usage of these platforms by both patients and physicians contributed to this positive result.<\/p>\n<p>Mr. Leonard added: We are particularly proud of our ability to reach new patients during this difficult time. In June, we experienced a record monthly high in new patient treatment starts, which supports a strong upward trend following the initial impact of the COVID-19 pandemic and positions us well for what we hope to be a strong third quarter.<\/p>\n<p>SELECTED SECOND QUARTER FINANCIAL AND OPERATING RESULTS (1) <\/p>\n<p>(US$)<\/p>\n<p>Q2 2020(unaudited) <\/p>\n<\/p>\n<p>Q2 2019(unaudited) <\/p>\n<\/p>\n<p>YTD 2020(unaudited) <\/p>\n<p>YTD 2019(unaudited) <\/p>\n<p>Total revenue<\/p>\n<p>9,788,555<\/p>\n<\/p>\n<p>8,082,559<\/p>\n<\/p>\n<p>21,209,057<\/p>\n<p>14,689,757<\/p>\n<p>Regional operating income (loss)<\/p>\n<p>(225,198)<\/p>\n<\/p>\n<p>1,002,166<\/p>\n<\/p>\n<p>514,598<\/p>\n<p>1,629,166<\/p>\n<p>Loss before income taxes<\/p>\n<p>(9,734,642)<\/p>\n<\/p>\n<p>(2,841,107)<\/p>\n<\/p>\n<p>(13,975,438)<\/p>\n<p>(5,481,194)<\/p>\n<p>Loss for the period and comprehensive loss<\/p>\n<p>(9,734,642)<\/p>\n<\/p>\n<p>(2,841,107)<\/p>\n<\/p>\n<p>(13,975,438)<\/p>\n<p>(5,481,194)<\/p>\n<p>Loss attributable to the common shareholders of Greenbrook<\/p>\n<p>(9,477,505)<\/p>\n<\/p>\n<p>(2,874,092)<\/p>\n<\/p>\n<p>(13,635,778)<\/p>\n<p>(5,444,514)<\/p>\n<p>Net loss per share (basic and diluted)<\/p>\n<p>(0.15)<\/p>\n<\/p>\n<p>(0.06)<\/p>\n<\/p>\n<p>(0.23)<\/p>\n<p>(0.11)<\/p>\n<p>(1)<\/p>\n<\/p>\n<p>Please note that additional selected consolidated financial information can be found at the end of this press release.<\/p>\n<\/p>\n<p>As at June 30,<\/p>\n<\/p>\n<p>As at December 31,<\/p>\n<p>(unaudited)<\/p>\n<\/p>\n<p>2020<\/p>\n<\/p>\n<p>2019<\/p>\n<\/p>\n<p>2019<\/p>\n<p>Number of active TMS Centers(1)<\/p>\n<p>113<\/p>\n<\/p>\n<p>67<\/p>\n<\/p>\n<p>102<\/p>\n<p>Number of TMS Centers-in-development(2)<\/p>\n<p>12<\/p>\n<\/p>\n<p>10<\/p>\n<\/p>\n<p>17<\/p>\n<p>Total TMS Centers <\/p>\n<p>125<\/p>\n<\/p>\n<p>77<\/p>\n<\/p>\n<p>119<\/p>\n<p>Number of management regions<\/p>\n<p>13<\/p>\n<\/p>\n<p>10<\/p>\n<\/p>\n<p>13<\/p>\n<p>Number of TMS Devices installed<\/p>\n<p>189<\/p>\n<\/p>\n<p>127<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More here:<\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.businesswire.com\/news\/home\/20200804006113\/en\/Greenbrook-TMS-Reports-Quarter-Financial-Results-Resilient\" title=\"Greenbrook TMS Reports Second Quarter Financial Results With Resilient Performance Through the COVID-19 Pandemic - Business Wire\">Greenbrook TMS Reports Second Quarter Financial Results With Resilient Performance Through the COVID-19 Pandemic - Business Wire<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (Greenbrook or the Company), today announced its second quarter 2020 (Q2 2020) operational and financial results.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/tms\/greenbrook-tms-reports-second-quarter-financial-results-with-resilient-performance-through-the-covid-19-pandemic-business-wire-8.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[431603],"tags":[],"class_list":["post-440634","post","type-post","status-publish","format-standard","hentry","category-tms"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/440634"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=440634"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/440634\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=440634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=440634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=440634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}